Thiabendazole (TBZ), an immunohemomodulator. II. Effects on thymocytes and prothymocytes

Int J Immunopharmacol. 1982;4(6):497-506. doi: 10.1016/0192-0561(82)90029-7.

Abstract

The purpose of this study was to document the effects of TBZ on the early stages of T cell maturation. The method utilized to quantify presumptive thymocyte progenitors in the bone marrow used the enzyme terminal deoxynucleotidyl transferase (TdT) as a marker. Shifts in thymocyte populations were determined by quantitative planimetry, immunofluorescence for TdT and tritiated thymidine incorporation. When given alone, TBZ produced a marked increase in the number of large, mitotically active lymphoblasts in the thymus cortex. When given with DNFB, a thymus-dependent neoantigen, TBZ produced a significant increase in TdT-positive bone marrow cells. In a companion study, TBZ + DNFB were found to stimulate T cells in lymph node and spleen. Hence, the results indicate that under appropriate conditions, TBZ can stimulate all stages of T cell differentiation in mice.

Publication types

  • Comparative Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adjuvants, Immunologic / pharmacology
  • Animals
  • Bone Marrow / drug effects
  • DNA Nucleotidylexotransferase / metabolism
  • Dinitrofluorobenzene / pharmacology
  • Female
  • Hematopoietic Stem Cells / drug effects*
  • Mice
  • Mice, Inbred C57BL
  • T-Lymphocytes / drug effects*
  • T-Lymphocytes / metabolism
  • Thiabendazole / pharmacology*
  • Thymidine / metabolism
  • Thymus Gland / anatomy & histology
  • Thymus Gland / drug effects

Substances

  • Adjuvants, Immunologic
  • Dinitrofluorobenzene
  • DNA Nucleotidylexotransferase
  • Thiabendazole
  • Thymidine